Lamotrigine versus carbamazepine monotherapy (single medication treatment) for epilepsy

Up to 70 million people worldwide have epilepsy and there are many Cochrane Reviews of ways to treat it. These include reviews that work with the original researchers to gather data on everyone who was in their studies, to perform individual participant data meta-analyses. In June 2018, Sarah Nevitt and colleagues from the University of Liverpool in the UK updated one of these reviews, comparing two commonly used drugs, lamotrigine and carbamazepine.
Source: Podcasts from The Cochrane Library - Category: General Medicine Authors: Source Type: podcasts